<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006742</article-id><article-id pub-id-type="pmc">PMC11861348</article-id><article-id pub-id-type="doi">10.3390/vaccines13020195</article-id><article-id pub-id-type="publisher-id">vaccines-13-00195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Amonabactin Synthetase G Regulates <italic toggle="yes">Aeromonas hydrophila</italic> Pathogenicity Through Modulation of Host Wnt/&#x003b2;-catenin Signaling</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Yiyang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; original draft/">Writing &#x02013; original draft</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref><xref rid="fn1-vaccines-13-00195" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiaofeng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; original draft/">Writing &#x02013; original draft</role><xref rid="af2-vaccines-13-00195" ref-type="aff">2</xref><xref rid="fn1-vaccines-13-00195" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Chuyi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yujun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding acquisition/">Funding acquisition</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Ye</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding acquisition/">Funding acquisition</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jiayi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Pingyuan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Zejun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; review &#x00026; editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding acquisition/">Funding acquisition</role><xref rid="af1-vaccines-13-00195" ref-type="aff">1</xref><xref rid="af3-vaccines-13-00195" ref-type="aff">3</xref><xref rid="c1-vaccines-13-00195" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Meurens</surname><given-names>Fran&#x000e7;ois</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-13-00195"><label>1</label>State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Sciences, Hunan Normal University, Changsha 410081, China; <email>tyy0808@hunnu.edu.cn</email> (Y.T.); <email>chuyizeng@hunnu.edu.cn</email> (C.Z.); <email>yujunliu@hunnu.edu.cn</email> (Y.L.); <email>yangye0622@hunnu.edu.cn</email> (Y.Y.); <email>hujiayi0211@hunnu.edu.cn</email> (J.H.); <email>lipingyuan0902@hunnu.edu.cn</email> (P.L.)</aff><aff id="af2-vaccines-13-00195"><label>2</label>Department of Nutrition, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China; <email>liuxiaofeng@csu.edu.cn</email></aff><aff id="af3-vaccines-13-00195"><label>3</label>Guangdong Provincial Key Laboratory of Aquatic Animal Disease Control and Healthy Culture, Guangdong Ocean University, Zhanjiang 524088, China</aff><author-notes><corresp id="c1-vaccines-13-00195"><label>*</label>Correspondence: <email>zhouzejun@hunnu.edu.cn</email>; Tel.: +86-731-8887-3074</corresp><fn id="fn1-vaccines-13-00195"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>195</elocation-id><history><date date-type="received"><day>03</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>10</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objectives: <italic toggle="yes">Aeromonas hydrophila</italic> is a significant opportunistic pathogen with a broad host range. It produces a catecholate siderophore, amonabactin, during iron starvation, but the in vivo infection mechanism that involves amonabactin is unclear. This study aims to elucidate the role of amonabactin synthetase G (AmoG) in the pathogenicity of <italic toggle="yes">A. hydrophila</italic> and its impact on gut barrier function. Methods: &#x00394;<italic toggle="yes">AmoG</italic> was generated by deleting the AMP-binding domain of AmoG in <italic toggle="yes">A. hydrophila</italic> CCL1. In vivo infection experiments were conducted to assess the mutant&#x02019;s iron-chelating ability and pathogenicity. Complementation of &#x00394;<italic toggle="yes">AmoG</italic> with AmoG (&#x00394;<italic toggle="yes">AmoG</italic>-C) was performed to confirm the observed phenotypes. Transcriptomic and qRT-PCR analyses were used to investigate gene expression changes in infected fish. Goblet cell counts, tight junction expression, and D-lactic acid and LPS levels were measured to evaluate gut barrier function. Results: &#x00394;<italic toggle="yes">AmoG</italic> exhibited impaired iron-chelating ability and reduced pathogenicity compared to wild-type CCL1. Complementation with AmoG restored virulence in &#x00394;<italic toggle="yes">AmoG</italic>-C. Transcriptomic and qRT-PCR analyses revealed an elevated expression of Wnt/&#x003b2;-catenin pathway components and antimicrobial genes in &#x00394;<italic toggle="yes">AmoG</italic>-infected fish. Further investigation indicated increased goblet cells and an enhanced expression of tight junctions, as well as lower D-lactic acid and LPS levels, in &#x00394;<italic toggle="yes">AmoG</italic>-infected fish. However, gut permeability, bacterial load, and lethality did not significantly differ between CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, and &#x00394;<italic toggle="yes">AmoG</italic>-C infections when the Wnt/&#x003b2;-catenin pathway was activated. Conclusions: AmoG plays a crucial role in <italic toggle="yes">A. hydrophila</italic> pathogenicity by modulating host Wnt/&#x003b2;-catenin signaling and gut mucosal barrier function. This study provides insights into the pathogenesis of <italic toggle="yes">A. hydrophila</italic> and potential therapeutic targets.</p></abstract><kwd-group><kwd>siderophore</kwd><kwd>amonabactin</kwd><kwd>tight junction</kwd><kwd>gut</kwd><kwd>crucian carp</kwd></kwd-group><funding-group><award-group><funding-source>National Key Research and Development Plan Program</funding-source><award-id>2024YFD2401104</award-id></award-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>32102847</award-id></award-group><award-group><funding-source>Natural Science Foundation of Hunan Province</funding-source><award-id>2024JJ5261</award-id></award-group><award-group><funding-source>Natural Science Foundation of Hunan Province for Young Student</funding-source><award-id>2024JJ10032</award-id></award-group><award-group><funding-source>Undergraduate Research Project of Shi-Cheng College of Hunan Normal University</funding-source></award-group><funding-statement>This research was supported by the National Key Research and Development Plan Program (2024YFD2401104), National Natural Science Foundation of China (32102847), Natural Science Foundation of Hunan Province (2024JJ5261), Natural Science Foundation of Hunan Province for Young Student (2024JJ10032), and Undergraduate Research Project of Shi-Cheng College of Hunan Normal University (Y.Y. and Y.L.).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-13-00195"><title>1. Introduction</title><p><italic toggle="yes">Aeromonas hydrophila</italic> is a ubiquitous pathogen within aquatic ecosystems and has led to substantial economic burdens for aquaculture [<xref rid="B1-vaccines-13-00195" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-13-00195" ref-type="bibr">2</xref>,<xref rid="B3-vaccines-13-00195" ref-type="bibr">3</xref>]. Several prominent virulence factors have been identified, such as Type Three Secretion Systems (T3SSs) and T6SSs; toxins like Alt (heat-labile cytotonic enterotoxin), Act (cytotoxic enterotoxin), Ahp (serine protease); and various hemolysins [<xref rid="B4-vaccines-13-00195" ref-type="bibr">4</xref>]. In addition, siderophores are crucial for <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> to override the iron limitations imposed by the host or the environment [<xref rid="B5-vaccines-13-00195" ref-type="bibr">5</xref>]. Amonabactins, siderophores produced by the <italic toggle="yes">Aeromonas</italic> genus, can be used for iron acquisition to support a bacterium&#x02019;s growth [<xref rid="B6-vaccines-13-00195" ref-type="bibr">6</xref>,<xref rid="B7-vaccines-13-00195" ref-type="bibr">7</xref>]. A previous study showed that <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> without the amonabactin biosynthesis gene <italic toggle="yes">AmoG</italic> was unable to synthesize any amonabactin or grow under iron stress conditions [<xref rid="B8-vaccines-13-00195" ref-type="bibr">8</xref>]. Nonetheless, the direct impact of <italic toggle="yes">A. hydrophila</italic>-produced amonabactin on host infection dynamics and its potential roles in modulating the fish epithelial barrier remain unexplored.</p><p>The integrity of the gut epithelial barrier is critical for preserving gut functionality and systemic immunity [<xref rid="B9-vaccines-13-00195" ref-type="bibr">9</xref>]. Pathogens employ different virulence mechanisms to disrupt epithelial junctions, thereby undermining gut barrier integrity [<xref rid="B10-vaccines-13-00195" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-13-00195" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-13-00195" ref-type="bibr">12</xref>]. <italic toggle="yes">A. hydrophila</italic>, notorious for its ability to severely compromise gut integrity and trigger septicemia, has been observed to cause gut lesions and induce gut inflammation in fish [<xref rid="B13-vaccines-13-00195" ref-type="bibr">13</xref>,<xref rid="B14-vaccines-13-00195" ref-type="bibr">14</xref>,<xref rid="B15-vaccines-13-00195" ref-type="bibr">15</xref>]. In a previous study, we identified a secretory serine protease (Ssp1) from <italic toggle="yes">A. hydrophila</italic> that plays a critical role in disrupting the gut&#x02019;s tight junction barrier [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>]. In addition, our earlier work pinpointed WbuB, a GT4 galactosaminogalactan synthase from <italic toggle="yes">A. hydrophila</italic>, as vital for inflammasome activation and gut tight junction disruption [<xref rid="B17-vaccines-13-00195" ref-type="bibr">17</xref>]. Nevertheless, the specifics of how <italic toggle="yes">A. hydrophila</italic> exploits nutrient acquisition, notably through amonabactin, to impact the gut mucosa barriers remain unclear.</p><p>In this study, we identified an amonabactin cluster with a potential iron uptake ability in <italic toggle="yes">A. hydrophila</italic> CCL1 (GenBank Accession No. CP092356). To elucidate this pathogenic mechanism, we selected the amonabactin biosynthesis gene <italic toggle="yes">AmoG</italic> for further study to determine whether it is a virulence factor in vivo. Through engineering &#x00394;<italic toggle="yes">AmoG</italic> and its complement strain, comparative analyses encompassing physiological attributes and virulence capacities were conducted for these strains. Moreover, in vivo studies suggested that <italic toggle="yes">A. hydrophila</italic> may use amonabactin as one of its virulence factors to inhibit the Wnt/&#x003b2;-catenin pathway, consequently impairing the structure and function of the gut mucosal barrier. Our findings suggested that, unlike Ssp1 and WbuB, which predominantly influence the tight junction and inflammasome pathway, AmoG seems to manipulate the host Wnt/&#x003b2;-catenin signaling pathway through nutrient acquisition. These results provide key insights into gut mucosal dysfunction during <italic toggle="yes">A. hydrophila</italic> infection.</p></sec><sec id="sec2-vaccines-13-00195"><title>2. Materials and Methods</title><sec id="sec2dot1-vaccines-13-00195"><title>2.1. Fish</title><p>Crucian carps (~14.2 g) were obtained from Hunan Yuelu Mountain Science and Technology Co., Ltd.: Changsha, China, which carries out aquatic breeding in Changsha. During the experiment, fish were housed pre-experimentally under controlled conditions (25.25 &#x000b1; 0.58 &#x000b0;C, pH 7.05 &#x000b1; 0.12, &#x0003e;7.0 mg/L O<sub>2</sub>). Pre-experimental screening confirmed that the fish were disease-free [<xref rid="B18-vaccines-13-00195" ref-type="bibr">18</xref>]. Tissues were acquired following ethical guidelines (GB/T 35892-2018 [<xref rid="B19-vaccines-13-00195" ref-type="bibr">19</xref>]). All animal experiments were approved by the Hunan Normal University&#x02019;s Animal Care Committee (No. 2023109).</p></sec><sec id="sec2dot2-vaccines-13-00195"><title>2.2. Generation of A. hydrophila &#x00394;AmoG and &#x00394;AmoG-C</title><p>To generate the <italic toggle="yes">A. hydrophila</italic> &#x00394;<italic toggle="yes">AmoG</italic> mutant, a 300 bp in-frame deletion of AmoG (aa 661&#x02013;760) was engineered via an overlap extension PCR. The primers AmoG-F1/AmoG-R1 and AmoG-F2/AmoG-R2 were used sequentially for overlap PCRs, followed by a fusion PCR using AmoG-F1/AmoG-R2 (<xref rid="app1-vaccines-13-00195" ref-type="app">Table S1</xref>). The resultant amplicon was ligated into pDM4 at the BglII site, yielding pDMAmoG. <italic toggle="yes">Escherichia coli</italic> S17-1 &#x003bb;pir harboring pDMAmoG was conjugated with <italic toggle="yes">A. hydrophila</italic> CCL1. Following coculture and selection on polymyxin B/chloramphenicol plates, sucrose-resistant yet chloramphenicol-sensitive colonies were isolated. Confirmation of in-frame deletion in these isolates was achieved through PCR and sequencing, leading to the identification of the &#x00394;<italic toggle="yes">AmoG</italic> mutant.</p><p>For the creation of the AmoG complement strain, designated &#x00394;<italic toggle="yes">AmoG</italic>-C, the gene encoding AmoG, along with its native promoter, was PCR-amplified using the primers AmoG-F3 and AmoG-R3 (<xref rid="app1-vaccines-13-00195" ref-type="app">Table S1</xref>). This amplicon was then cloned into the pACYC184 plasmid at its EcoRV restriction site, forming pACYCAmoG-C. Subsequently, this construct was introduced into <italic toggle="yes">E. coli</italic> S17-1 &#x003bb;pir, which was subsequently mated with the &#x00394;<italic toggle="yes">AmoG</italic> mutant. Transconjugants were identified on selective LB agar plates containing polymyxin B and chloramphenicol. One selected colony, designated &#x00394;<italic toggle="yes">AmoG</italic>-C, was further validated by PCR and sequence confirmation.</p></sec><sec id="sec2dot3-vaccines-13-00195"><title>2.3. Characterization of &#x00394;AmoG and &#x00394;AmoG-C</title><p>The strains CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, and &#x00394;<italic toggle="yes">AmoG</italic>-C were cultured in LB broth at 28 &#x000b0;C for 24 h. Scanning electron microscopy was employed to assess cell morphology. Growth dynamics were monitored by cultivating the strains in LB with or without 100 &#x003bc;M 2, 2&#x02032;-dipyridyl (Dp), starting at an A600 of 0.01; samples were taken at various intervals to measure A600. Motility assays and biofilm formation tests were conducted according to Reference [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>]. The Chrome Azurol S (CAS) plate assay and Arnow&#x02019;s test were used to analyze siderophore production according to Reference [<xref rid="B20-vaccines-13-00195" ref-type="bibr">20</xref>]. Each assay was replicated three times.</p></sec><sec id="sec2dot4-vaccines-13-00195"><title>2.4. Cellular Adherence and Cytotoxicity Analyses</title><p>Caco-2 cells, obtained from American Type Culture Collection (ATCC, Manassas, VA, USA), were maintained in DMEM enriched with 20% FBS and antibiotics (penicillin/streptomycin) at 37 &#x000b0;C in 5% CO<sub>2</sub>. Approximately 1 &#x000d7; 10<sup>5</sup> Caco-2 cells were seeded into 96-well plates and infected with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) at an MOI of 10:1. Cells were incubated for 1 h before washing away unbound bacteria using PBS. After infection, cells were lysed with Triton X-100, and the lysates were spread on LB agar to determine the bacterial counts. The adhesion index was calculated as the ratio of associated bacteria to Caco-2 cells. Each assay was replicated three times. Cytotoxicity was measured by the lactate dehydrogenase (LDH) method. Briefly, after 1 h of infection as above, LDH leakage was assessed using a Cytotoxicity Detection Kit (Roche Diagnostics, Mannheim, Germany). Cells treated with Triton X-100 represented the maximum LDH release (100%). Each assay was replicated three times.</p></sec><sec id="sec2dot5-vaccines-13-00195"><title>2.5. In Vivo Infection</title><p>For in vivo infection, fish were injected intramuscularly (i.m.) with 100 &#x000b5;L suspensions containing 1 &#x000d7; 10<sup>6</sup> CFU/mL of CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or an equivalent volume of PBS (control). At 24 h post infection (hpi), distal gut, kidney, spleen, and blood from CCL1-, &#x00394;<italic toggle="yes">AmoG-</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C-, or PBS (control)-treated fish were carefully sampled under sterile conditions for subsequent experimental procedures. (i) Bacterial dissemination in the kidney and spleen and AB-PAS staining were carried out as reported previously [<xref rid="B21-vaccines-13-00195" ref-type="bibr">21</xref>]. (ii) A qRT-PCR was performed to analyze the genes&#x02019; expression in the distal gut. The genes and PCR primers used are listed in <xref rid="app1-vaccines-13-00195" ref-type="app">Table S1</xref>. Expression levels were measured through the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method, referencing beta-actin, with PCR efficiency (E) and correlation (R<sup>2</sup>) checked as previously detailed [<xref rid="B22-vaccines-13-00195" ref-type="bibr">22</xref>]. (iii) Plasma was derived from the blood of each group. D-lactic acid concentrations were measured using a D-lactic acid ELISA assay kit procured from Nanjing Jiancheng Bioengineering Institute, Nanjing, China. Additionally, Limulus Amebocyte Lysate (LAL) QCL-1000 kits from Lonza were employed to quantify lipopolysaccharide (LPS) levels within the plasma. (iv) An immunohistochemistry (IHC) assay was used to analyze the expression of Occludin in the distal gut as reported previously [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>]. Mouse anti-rOccludin antibody (prepared in [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>]) and Cy3-conjugated goat anti-mouse secondary antibody (Servicebio, Wuhan, China) were used as the primary and secondary antibodies, respectively. (v) Iron concentrations in the serum and distal gut were determined using an iron-unsaturated iron binding capacity kit (Nanjing Jiancheng) according to the manufacturer&#x02019;s instruction. The DAB-enhanced Prussian blue iron staining kit (Servicebio, Wuhan, China) was utilized to detect iron deposits within liver samples according to the manufacturer&#x02019;s instructions. (vi) To conduct an apoptosis assessment targeting the distal guts, an apoptosis assay was carried out using the TUNEL Apoptosis Detection Kit (Servicebio). (vii) For assessing survival rates, twenty crucian carps per group were challenged with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or received a PBS control, following the same inoculation procedure as described above. Over a period of two weeks, fish mortality was meticulously documented post infection as reported previously [<xref rid="B21-vaccines-13-00195" ref-type="bibr">21</xref>]. Each assay was replicated three times, with three fish used each time.</p></sec><sec id="sec2dot6-vaccines-13-00195"><title>2.6. Gut Transcriptome and Microbiome Analyses</title><p>Transcriptome analysis was performed as outlined in previous work [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>]. At 24 hpi, as above, distal guts from fish infected with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or exposed to PBS (serving as control) were collected under sterile conditions (with four fish in each group). Gut specimens from each group were frozen at &#x02212;80 &#x000b0;C prior to RNA extraction for subsequent RNA sequencing (RNA-Seq). RNA extraction, library construction, and data analysis were performed by Novogene (Beijing, China).</p><p>For a comprehensive analysis of the microbiome shifts in the guts of fish exposed to CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or treated with PBS (control), as above, distal guts from each group were taken and forwarded to Novogene for expert processing and sequencing (with four fish in each group). Following CTAB/SDS DNA extraction, libraries were constructed and sequenced using the 515F and 806R primer pair on an Illumina NovaSeq6000. Rigorous data analysis was performed through QIIME2 as reported previously [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>].</p></sec><sec id="sec2dot7-vaccines-13-00195"><title>2.7. Effect of the Activation of the Wnt/&#x003b2;-Catenin Pathway on Infection</title><p>Fish (twenty fish in each group) were injected i.m. with 100 &#x000b5;L of the Wnt/&#x003b2;-catenin agonist BIO (0.5 mg/mL, Sigma, St. Louis, MO, USA). Two hours following the initial procedure, each fish received an intramuscular injection comprising 100 &#x000b5;L of suspension, with concentrations of 1 &#x000d7; 10<sup>6</sup> CFU/mL for either CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS. At 24 hpi, the kidney, spleen, and blood from CCL1-, &#x00394;<italic toggle="yes">AmoG-</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C-, or PBS (control)-injected fish were carefully sampled as above. Plasma LPS levels, bacterial dissemination, and survival rate assays were determined as reported above. Each assay was replicated three times.</p></sec><sec id="sec2dot8-vaccines-13-00195"><title>2.8. Statistical Analysis</title><p>The sample size was calculated using PASS software (PASS 11. NCSS, LLC. Kaysville, UT, USA). Data were statistically analyzed using GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA) and the Unpaired Mann&#x02013;Whitney test or the Log-Rank test.</p></sec></sec><sec sec-type="results" id="sec3-vaccines-13-00195"><title>3. Results</title><sec id="sec3dot1-vaccines-13-00195"><title>3.1. Phenotypic Characterization of &#x00394;AmoG</title><p><italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> produces a catecholate siderophore named amonabactin in response to iron starvation. A thorough examination of the genomic sequence of the fish pathogen <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> CCL1 (GenBank Accession No. CP092356) unveiled a gene cluster likely implicated in amonabactin production (<xref rid="app1-vaccines-13-00195" ref-type="app">Figure S1</xref>). This gene cluster possesses <italic toggle="yes">AmoC</italic>, <italic toggle="yes">AmoE</italic>, <italic toggle="yes">AmoB</italic>, <italic toggle="yes">AmoF</italic>, <italic toggle="yes">AmoA</italic>, <italic toggle="yes">AmoG,</italic> and <italic toggle="yes">AmoH</italic> (<xref rid="app1-vaccines-13-00195" ref-type="app">Figure S1</xref>). We focused on the potential amonabactin synthetase G (<italic toggle="yes">AmoG</italic>) from <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> CCL1 for further analysis. The deduced amino acid sequence of AmoG is composed of 2089 residues (GenBank Accession No. XIH98845.1). Sequence alignment shows that AmoG shares 94.5&#x02013;26.4% overall sequence identities with homologs from <italic toggle="yes">A</italic>. <italic toggle="yes">veronii</italic>, <italic toggle="yes">A</italic>. <italic toggle="yes">salmonicida</italic>, <italic toggle="yes">Vibrio parahaemolyticus</italic>, <italic toggle="yes">V</italic>. <italic toggle="yes">alginolyticus</italic>, <italic toggle="yes">V</italic>. <italic toggle="yes">harveyi</italic>, <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Campylobacter jejuni,</italic> and <italic toggle="yes">Yersinia enterocolitica</italic> (<xref rid="app1-vaccines-13-00195" ref-type="app">Figure S2</xref>). SMART could predict an AMP-binding domain (from 537 to 923 aa) and three Pfam condensations in AmoG (<xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>A).</p><p>To probe AmoG&#x02019;s role in pathogenicity, we engineered a variant of <italic toggle="yes">A. hydrophila</italic> CCL1, termed &#x00394;<italic toggle="yes">AmoG</italic>, featuring an in-frame deletion of the AmoG segment (residues 661&#x02013;760, <xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>B). We also generated a complemented strain, &#x00394;<italic toggle="yes">AmoG</italic>-C, reintroducing a functional AmoG to &#x00394;<italic toggle="yes">AmoG</italic> (<xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>B). Both &#x00394;<italic toggle="yes">AmoG</italic> and &#x00394;<italic toggle="yes">AmoG</italic>-C exhibited similar morphology and growth to their parental CCL1 in LB media (<xref rid="vaccines-13-00195-t001" ref-type="table">Table 1</xref>, <xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>C), without noticeable changes in biofilm formation or swimming motility (<xref rid="vaccines-13-00195-t001" ref-type="table">Table 1</xref>). While CCL1 had an LD<sub>50</sub> of 9.26 &#x000d7; 10<sup>4</sup> CFU/fish, &#x00394;<italic toggle="yes">AmoG</italic> displayed a reduced virulence, with an LD<sub>50</sub> of 8.58 &#x000d7; 10<sup>5</sup> CFU/fish, indicating a roughly ten-fold decrease (<xref rid="vaccines-13-00195-t001" ref-type="table">Table 1</xref>). In addition, under the iron-depleted condition imposed by adding 100 &#x000b5;M Dp, both CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C demonstrated a suppressed growth level; however, &#x00394;<italic toggle="yes">AmoG</italic> was virtually incapable of growing in such an environment (<xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>C). Furthermore, &#x00394;<italic toggle="yes">AmoG</italic> failed to produce the expected yellow hue in CAS medium, indicating its role in iron&#x02013;siderophore interactions (<xref rid="vaccines-13-00195-f001" ref-type="fig">Figure 1</xref>D). This observation underscores AmoG&#x02019;s critical role in facilitating metabolic adaptations for iron uptake, revealing its importance in enabling survival under conditions of iron scarcity.</p></sec><sec id="sec3dot2-vaccines-13-00195"><title>3.2. AmoG-Mediated Iron Chelation and Bacterial Infection</title><p>Following the above findings, which suggested a deficiency in the iron-chelating process of the &#x00394;<italic toggle="yes">AmoG</italic> strain, we proceeded to investigate whether there was an alteration in its capability to produce siderophore. The Arnow assay confirmed that &#x00394;<italic toggle="yes">AmoG</italic> exhibited a significantly diminished ability to synthesize the iron-chelating siderophore amonabactin (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>A). When incubated with Caco-2 cells, an intestinal epithelial cell line, notably reduced adherence and cytotoxicity were found in the &#x02206;<italic toggle="yes">AmoG</italic>-treated group compared to the CCL1- and &#x00394;<italic toggle="yes">AmoG</italic>-C-treated groups (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>B,C). Moreover, iron levels in the serum, gut, and liver of fish infected with CCL1 and &#x02206;<italic toggle="yes">AmoG</italic>-C were substantially lower than those seen after infection with &#x02206;<italic toggle="yes">AmoG</italic> (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>D&#x02013;F). This finding suggested that the deletion of AmoG in <italic toggle="yes">A. hydrophila</italic> led to an accumulation of iron in these tissues, potentially due to the impaired iron-chelating abilities of the bacteria. Following up on these observations of the effects of AmoG on the iron-chelating process, a TUNEL analysis was used to investigate cell apoptosis under iron deficiency conditions. The result showed that distal gut apoptosis was significantly lower in &#x02206;<italic toggle="yes">AmoG</italic>-infected fish compared to those with CCL1 or &#x02206;<italic toggle="yes">AmoG</italic>-C infections (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>G,H). Upon analyzing the bacterial loads within the distal guts, kidneys, and spleens of infected fish, we observed considerably lower numbers of <italic toggle="yes">A. hydrophila</italic> in those infected with the &#x02206;<italic toggle="yes">AmoG</italic> strain (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>I&#x02013;K). Correspondingly, there was a notable decline in mortality among &#x02206;<italic toggle="yes">AmoG</italic>-infected fish, indicating that the virulence of &#x02206;<italic toggle="yes">AmoG</italic> had been significantly dampened (<xref rid="vaccines-13-00195-f002" ref-type="fig">Figure 2</xref>L). These results suggest that <italic toggle="yes">A. hydrophila</italic> may employ AmoG in the synthesis of amonabactin to facilitate iron chelation, consequently impairing the structure and function of the gut mucosal barrier.</p></sec><sec id="sec3dot3-vaccines-13-00195"><title>3.3. Transcriptomic Analysis</title><p>To further investigate the pathogenic mechanism orchestrated by AmoG, we conducted transcriptomic analyses on the distal guts of <italic toggle="yes">A. hydrophila</italic>-infected crucian carps. The results revealed that compared to &#x00394;<italic toggle="yes">AmoG</italic> infection, CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C infection notably repressed the expression of several key genes, including <italic toggle="yes">wnt10b</italic>, <italic toggle="yes">axin2</italic>, <italic toggle="yes">ccnd1,</italic> and <italic toggle="yes">ctnnb1</italic>, whereas genes like <italic toggle="yes">IL-8</italic>, <italic toggle="yes">ptx3a,</italic> and <italic toggle="yes">hsp90b1</italic> experienced pronounced upregulation (<xref rid="vaccines-13-00195-f003" ref-type="fig">Figure 3</xref>A,B). A further KEGG pathway analysis highlighted that the Wnt/&#x003b2;-catenin signaling pathway (a key regulator of cell proliferation, differentiation, and homeostasis) was significantly impacted during &#x00394;<italic toggle="yes">AmoG</italic> infection, underscoring its pivotal role in mediating disease progression and the host&#x02019;s response (<xref rid="vaccines-13-00195-f003" ref-type="fig">Figure 3</xref>C&#x02013;F). This finding also suggested a possible connection between the AmoG-mediated iron-chelating process and the Wnt/&#x003b2;-catenin signaling pathway.</p></sec><sec id="sec3dot4-vaccines-13-00195"><title>3.4. Impact of AmoG on the Wnt/&#x003b2;-Catenin Pathway</title><p>The Wnt/&#x003b2;-catenin signaling pathway is fundamental for the regeneration of the gut mucosal barrier. Given that transcriptomic data suggested a disruption of the Wnt/&#x003b2;-catenin pathway during <italic toggle="yes">A. hydrophila</italic> infection, we proceeded to examine the effect of the Wnt/&#x003b2;-catenin pathway on the gut mucosal barrier. Initially, consistent with the transcriptomic data, key components of the Wnt/&#x003b2;-catenin pathway, such as <italic toggle="yes">wnt3a</italic>, <italic toggle="yes">wnt10b</italic>, <italic toggle="yes">ctnnb1</italic>, and <italic toggle="yes">Lgr6</italic>, displayed a significantly upregulated expression in the fish treated with &#x00394;<italic toggle="yes">AmoG</italic> relative to those treated with CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C (<xref rid="vaccines-13-00195-f004" ref-type="fig">Figure 4</xref>A&#x02013;D). Subsequently, AB-PAS staining indicated that the counts of distal gut goblet cells in &#x00394;<italic toggle="yes">AmoG</italic>-infected fish notably surpassed those seen in CCL1- and &#x00394;<italic toggle="yes">AmoG</italic>-C-infected fish (<xref rid="vaccines-13-00195-f004" ref-type="fig">Figure 4</xref>E,F). IL-22, known to foster gut epithelial cell proliferation and antimicrobial peptide synthesis [<xref rid="B23-vaccines-13-00195" ref-type="bibr">23</xref>], also exhibited heightened expression in the distal guts following &#x00394;<italic toggle="yes">AmoG</italic> administration (<xref rid="vaccines-13-00195-f004" ref-type="fig">Figure 4</xref>G). Moreover, a qRT-PCR revealed an upsurged expression of <italic toggle="yes">MUC2</italic>, <italic toggle="yes">LEAP-2</italic>, and <italic toggle="yes">Hepcidin-1</italic> in &#x00394;<italic toggle="yes">AmoG</italic>-treated fish compared to CCL1- or &#x00394;<italic toggle="yes">AmoG</italic>-C-treated fish (<xref rid="vaccines-13-00195-f004" ref-type="fig">Figure 4</xref>H&#x02013;J). Conversely, fish treated with CCL1 or &#x00394;<italic toggle="yes">AmoG</italic>-C demonstrated a suppressed expression of these genes. These results indicated that without AmoG as a key virulence factor to synthesize amonabactin, the &#x02206;<italic toggle="yes">AmoG</italic> mutant&#x02019;s capacity to inhibit the Wnt/&#x003b2;-catenin pathway was markedly reduced.</p></sec><sec id="sec3dot5-vaccines-13-00195"><title>3.5. Impact of AmoG on Gut Mucosal Barrier</title><p>Given the marked reduction in &#x00394;<italic toggle="yes">AmoG</italic>&#x02019;s capacity to inhibit the Wnt/&#x003b2;-catenin pathway, we proceeded to investigate its influence on the gut mucosal barrier. THe qRT-PCR showed that a heightened expression of <italic toggle="yes">Occludin</italic> was observed in the distal gut of &#x00394;<italic toggle="yes">AmoG</italic>-exposed fish, compared to that in both the CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C groups (<xref rid="vaccines-13-00195-f005" ref-type="fig">Figure 5</xref>A,B). The IHC analysis also demonstrated that, unlike in CCL1- or &#x00394;<italic toggle="yes">AmoG</italic>-C-treated fish, Occludin, a vital tight junction constituent, was markedly upregulated in the distal guts of &#x00394;<italic toggle="yes">AmoG</italic>-treated fish (<xref rid="vaccines-13-00195-f005" ref-type="fig">Figure 5</xref>E). Additionally, plasma D-lactic acid and LPS, markers of gut lining integrity [<xref rid="B24-vaccines-13-00195" ref-type="bibr">24</xref>], were notably lower in &#x00394;<italic toggle="yes">AmoG</italic>-infected fish compared to those with CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C infections (<xref rid="vaccines-13-00195-f005" ref-type="fig">Figure 5</xref>H,I). Since disrupted gut barrier function can lead to alterations in the gut microbiota, we also investigated the gut microbiome differences among fish infected with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, or &#x00394;<italic toggle="yes">AmoG</italic>-C (<xref rid="app1-vaccines-13-00195" ref-type="app">Figure S3</xref>). The results showed that CCL1 infection led to discernible alterations in the gut microbiota compared to &#x00394;<italic toggle="yes">AmoG</italic> infection, indicating that the &#x02206;<italic toggle="yes">AmoG</italic> mutant exhibited a diminished ability to compromise the gut mucosal barrier.</p></sec><sec id="sec3dot6-vaccines-13-00195"><title>3.6. Impact of the Wnt/&#x003b2;-Catenin Pathway on Bacterial Infection</title><p>To further explore the impact of Wnt/&#x003b2;-catenin signaling pathway activation on <italic toggle="yes">A. hydrophila</italic> infection, we pre-treated fish with the Wnt/&#x003b2;-catenin pathway activator BIO before infecting them with either CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, or &#x00394;<italic toggle="yes">AmoG</italic>-C. Our results revealed that upon activation of the Wnt/&#x003b2;-catenin signaling pathway, the gut permeability of these fish, as well as the bacterial burdens in their kidneys and spleens, showed no significant differences among the infections caused by CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, or &#x00394;<italic toggle="yes">AmoG</italic>-C (<xref rid="vaccines-13-00195-f006" ref-type="fig">Figure 6</xref>A&#x02013;C). Similarly, the lethal effects attributed to each bacterial strain remained statistically indistinguishable following the activation of the Wnt/&#x003b2;-catenin pathway (<xref rid="vaccines-13-00195-f006" ref-type="fig">Figure 6</xref>D). In summary, these findings suggest that once the Wnt/&#x003b2;-catenin pathway is activated, the presence or absence of amonabactin does not appear to significantly influence the bacterium&#x02019;s infectivity. Additionally, these results suggest that <italic toggle="yes">A. hydrophila</italic> may employ amonabactin as a strategic tool to dampen the Wnt/&#x003b2;-catenin signaling pathway, which in turn facilitates the bacterium&#x02019;s ability to be invasive, making this a probable mechanism underlying its pathogenicity (<xref rid="app1-vaccines-13-00195" ref-type="app">Figure S4</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-13-00195"><title>4. Discussion</title><p>Iron is an essential trace element for most organisms [<xref rid="B25-vaccines-13-00195" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-13-00195" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-13-00195" ref-type="bibr">27</xref>]. In response to iron starvation, <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> has been shown to possess multiple systems for the sequestration of host iron, including heme-bound iron transport [<xref rid="B28-vaccines-13-00195" ref-type="bibr">28</xref>], the utilization of enterobactin siderophores produced by Enterobacteriaceae [<xref rid="B6-vaccines-13-00195" ref-type="bibr">6</xref>,<xref rid="B7-vaccines-13-00195" ref-type="bibr">7</xref>], and the secretion of amonabactin [<xref rid="B29-vaccines-13-00195" ref-type="bibr">29</xref>]. Among these virulence factors, amonabactin represents a family of catechol peptidic siderophores that is composed of seven genes named <italic toggle="yes">AmoCEBFAGH</italic> [<xref rid="B8-vaccines-13-00195" ref-type="bibr">8</xref>]. A previous study indicated that a mutant of AmoG was unable to synthesize any amonabactin or to grow in iron-stress conditions [<xref rid="B8-vaccines-13-00195" ref-type="bibr">8</xref>]. Consistent with this study, our results showed that under a treatment with 100 &#x000b5;M Dp, &#x00394;<italic toggle="yes">AmoG</italic> was almost unable to grow, indicating that the AmoG of <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> CCL1 may be involved in bacterial iron acquisition and survival under iron stress.</p><p>Until now, AmoG&#x02019;s in vivo function has remained unexplored experimentally. To explore this, firstly, we embarked on a comprehensive transcriptomic analysis targeting the guts of crucian carps infected with <italic toggle="yes">A. hydrophila</italic>. Our findings unveiled that in comparison to &#x00394;<italic toggle="yes">AmoG</italic> infections, CCL1 and &#x00394;<italic toggle="yes">AmoG</italic>-C infections markedly suppressed the expression of pivotal genes in the Wnt/&#x003b2;-catenin signaling pathway including <italic toggle="yes">wnt10b</italic>, <italic toggle="yes">axin2</italic>, <italic toggle="yes">ccnd1,</italic> and <italic toggle="yes">ctnnb1</italic>. The Wnt/&#x003b2;-catenin pathway is integral to the structural integrity of the gut barrier and is essential for the proper functioning of gut epithelial cells, such as goblet cells [<xref rid="B30-vaccines-13-00195" ref-type="bibr">30</xref>]. In line with the above observations, we observed a significant decline in goblet cells and <italic toggle="yes">MUC2</italic>, <italic toggle="yes">IL-22</italic>, <italic toggle="yes">Hepcidin-1,</italic> and <italic toggle="yes">LEAP-2</italic> expression in fish subjected to CCL1 or &#x00394;<italic toggle="yes">AmoG</italic>-C infection. These results indicated that AmoG may be involved in the pathogenicity of <italic toggle="yes">A</italic>. <italic toggle="yes">hydrophila</italic> infection through the inhibition of the Wnt/&#x003b2;-catenin pathway. Secondly, the Wnt/&#x003b2;-catenin pathway promotes the assembly and stability of gut tight junctions, ensuring minimal paracellular leakage [<xref rid="B31-vaccines-13-00195" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-13-00195" ref-type="bibr">32</xref>]. Previous investigations have documented the capacity of specific pathogens, notably <italic toggle="yes">Helicobacter pylori</italic> and <italic toggle="yes">Campylobacter jejuni</italic>, to inhibit the Wnt/&#x003b2;-catenin pathway and compromise the integrity of tight junctions during the course of their infection [<xref rid="B33-vaccines-13-00195" ref-type="bibr">33</xref>]. For this purpose, we analyzed the impact of AmoG on gut permeability in an in vivo setting. Our findings revealed a significant upregulation of occludin in fish infected with &#x00394;<italic toggle="yes">AmoG</italic>. Consistently, the decreased concentrations of plasma D-lactic acid and LPS indicated a reduced gut mucosal permeability following &#x00394;<italic toggle="yes">AmoG</italic> infection. Moreover, our data demonstrated a slight but notable enhancement in alpha diversity within the gut flora of fish infected with &#x00394;<italic toggle="yes">AmoG</italic> relative to those harboring CCL1, hinting at potential disturbances in bacterial colonization elicited by AmoG [<xref rid="B34-vaccines-13-00195" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-13-00195" ref-type="bibr">35</xref>]. Collectively, the above results suggested that AmoG might be involved in the infection process, particularly under conditions of an inhibited Wnt/&#x003b2;-catenin pathway and disrupted tight junction barriers. However, additional studies are warranted to validate whether AmoG&#x02019;s effects are direct or mediated indirectly through other pathways.</p><p>Iron is an indispensable micronutrient for bacterial metabolism, proliferation, and infection. Bacterial pathogens have developed intricate systems for iron acquisition, employing iron carriers known as siderophores to chelate and sequester iron from the host environment, influencing their infection capacities [<xref rid="B36-vaccines-13-00195" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-13-00195" ref-type="bibr">37</xref>]. Similarly, our results demonstrated that &#x00394;<italic toggle="yes">AmoG</italic> infection leads to elevated iron levels in the serum, gut, and liver of infected fish, possibly due to its impaired iron-chelating efficiency, which may subsequently affect the infection dynamics of <italic toggle="yes">A. hydrophila</italic>. Indeed, upon infecting fish with &#x00394;<italic toggle="yes">AmoG</italic>, we observed notably smaller bacterial counts in their tissues compared to those in fish infected with <italic toggle="yes">CCL1</italic>. The reason may be that the iron-chelating process used by <italic toggle="yes">A. hydrophila</italic> enables the bacterium to disrupt the gut barrier and simultaneously enhance its invasive capabilities. Research suggests that the inhibition of the Wnt/&#x003b2;-catenin signaling pathway by pathogens through iron chelation provides the bacteria with an advantage in disrupting the gut barrier, thereby enhancing their invasiveness [<xref rid="B38-vaccines-13-00195" ref-type="bibr">38</xref>]. Studies have reported that a shortage of iron, brought about by siderophores, can lead to the suppression of the Wnt/&#x003b2;-catenin signaling pathway, favoring bacterial infection [<xref rid="B39-vaccines-13-00195" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-13-00195" ref-type="bibr">40</xref>]. Consistent with these findings, our findings revealed that once the Wnt/&#x003b2;-catenin pathway is activated, the presence or absence of amonabactin does not seem to significantly alter the bacterium&#x02019;s infectivity. This observation further points to the possibility that <italic toggle="yes">A. hydrophila</italic> may use amonabactin as one of its virulence factors to inhibit the Wnt/&#x003b2;-catenin pathway and consequently impair the structure and function of the gut mucosal barrier. In addition, a study on <italic toggle="yes">Edwardsiella piscicida</italic> highlights the role of Fur in iron regulation and virulence, similar to the role of AmoG in <italic toggle="yes">A. hydrophila</italic>. In the future, using siderophore-deficient strains as vaccines may be an effective prevention and control strategy in aquaculture [<xref rid="B41-vaccines-13-00195" ref-type="bibr">41</xref>].</p><p>Interestingly, our previous studies have identified Ssp1 and WbuB as essential components for disrupting the gut&#x02019;s tight junction barrier [<xref rid="B16-vaccines-13-00195" ref-type="bibr">16</xref>,<xref rid="B17-vaccines-13-00195" ref-type="bibr">17</xref>]. In contrast to Ssp1 and WbuB, which primarily influence the tight junction and inflammasome pathway, AmoG uniquely targets the Wnt/&#x003b2;-catenin signaling pathway. Through iron acquisition, AmoG appears to manipulate the host&#x02019;s Wnt/&#x003b2;-catenin signaling pathway, thereby facilitating both pathogenesis and nutrient acquisition. Further exploration is needed to understand the precise mechanisms linking iron chelation to the mediation of the Wnt/&#x003b2;-catenin signaling pathway.</p></sec><sec sec-type="conclusions" id="sec5-vaccines-13-00195"><title>5. Conclusions</title><p>In conclusion, our findings indicate that AmoG is a previously unrecognized determinant in the pathogenicity of <italic toggle="yes">A. hydrophila</italic>, essential for successful host invasion. Our observations highlight AmoG&#x02019;s substantial disruption of the Wnt/&#x003b2;-catenin signaling pathway and gut barrier integrity. Moreover, the diminished expression of AmoG correlates with reduced <italic toggle="yes">A. hydrophila</italic> colonization in key immune tissues, significantly attenuating its virulence. These discoveries offer new perspectives on <italic toggle="yes">A. hydrophila</italic>&#x02019;s pathogenesis, contributing valuable knowledge to the prevention and treatment of this aquatic pathogen.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vaccines-13-00195"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vaccines13020195/s1">https://www.mdpi.com/article/10.3390/vaccines13020195/s1</uri>, Figure S1: Genomic organization of the amonabactin synthesis gene cluster in <italic toggle="yes">Aeromonas hydrophila</italic> CCL1 (GenBank Accession No. CP092356); Figure S2: Alignment of AmoG; Figure S3: Effect of AmoG on gut microbiota in vivo; Figure S4: Summary depiction suggesting a possible mechanism by which <italic toggle="yes">Aeromonas hydrophila</italic> AmoG modulates the infectivity through the manipulation of the Wnt/&#x003b2;-catenin pathway; Table S1: PCR primers used in this study.</p><supplementary-material id="vaccines-13-00195-s001" position="float" content-type="local-data"><media xlink:href="vaccines-13-00195-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Y.T.: Writing&#x02014;original draft, investigation. X.L.: Writing&#x02014;original draft, investigation. C.Z.: Investigation. Y.L.: Investigation, funding acquisition. Y.Y.: Investigation, funding acquisition. J.H.: Investigation. P.L.: Investigation. Z.Z.: Writing&#x02014;review and editing, project administration, funding acquisition. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Hunan Normal University&#x02019;s Animal Care Committee (no. 2023109, Approval Date 7 March 2023).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data from the RNA-Seq and 16S rDNA Amplicon Sequencing have been uploaded to the NCBI Sequence Read Archive under accession numbers PRJNA1192974 and PRJNA807750.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-13-00195"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stratev</surname><given-names>D.</given-names></name>
<name><surname>Odeyemi</surname><given-names>O.A.</given-names></name>
</person-group><article-title>Antimicrobial Resistance of <italic toggle="yes">Aeromonas hydrophila</italic> Isolated from Different Food Sources: A mini-Review</article-title><source>J. Infect. Public Health</source><year>2016</year><volume>9</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2015.10.006</pub-id><pub-id pub-id-type="pmid">26588876</pub-id>
</element-citation></ref><ref id="B2-vaccines-13-00195"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fern&#x000e1;ndez-Bravo</surname><given-names>A.</given-names></name>
<name><surname>Figueras</surname><given-names>M.J.</given-names></name>
</person-group><article-title>An Update on the Genus <italic toggle="yes">Aeromonas</italic>: Taxonomy, Epidemiology, and Pathogenicity</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8010129</pub-id><pub-id pub-id-type="pmid">31963469</pub-id>
</element-citation></ref><ref id="B3-vaccines-13-00195"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Awan</surname><given-names>F.</given-names></name>
<name><surname>Dong</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Ma</surname><given-names>K.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>The Fight for Invincibility: Environmental Stress Response Mechanisms and <italic toggle="yes">Aeromonas hydrophila</italic></article-title><source>Microb. Pathog.</source><year>2018</year><volume>116</volume><fpage>135</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.01.023</pub-id><pub-id pub-id-type="pmid">29355702</pub-id>
</element-citation></ref><ref id="B4-vaccines-13-00195"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rasmussen-Ivey</surname><given-names>C.R.</given-names></name>
<name><surname>Figueras</surname><given-names>M.J.</given-names></name>
<name><surname>McGarey</surname><given-names>D.</given-names></name>
<name><surname>Liles</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Virulence Factors of <italic toggle="yes">Aeromonas hydrophila</italic>: In the Wake of Reclassification</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><elocation-id>1337</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.01337</pub-id><pub-id pub-id-type="pmid">27610107</pub-id>
</element-citation></ref><ref id="B5-vaccines-13-00195"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cisneros-Sureda</surname><given-names>J.</given-names></name>
<name><surname>Rey-Varela</surname><given-names>D.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>J.</given-names></name>
<name><surname>Balado</surname><given-names>M.</given-names></name>
<name><surname>Lemos</surname><given-names>M.L.</given-names></name>
<name><surname>Jim&#x000e9;nez</surname><given-names>C.</given-names></name>
</person-group><article-title>Selective Detection of <italic toggle="yes">Aeromonas</italic> spp. by a Fluorescent Probe Based on the Siderophore Amonabactin</article-title><source>J. Inorg. Biochem.</source><year>2022</year><volume>230</volume><elocation-id>111743</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2022.111743</pub-id><pub-id pub-id-type="pmid">35124539</pub-id>
</element-citation></ref><ref id="B6-vaccines-13-00195"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Funahashi</surname><given-names>T.</given-names></name>
<name><surname>Tanabe</surname><given-names>T.</given-names></name>
<name><surname>Miyamoto</surname><given-names>K.</given-names></name>
<name><surname>Tsujibo</surname><given-names>H.</given-names></name>
<name><surname>Maki</surname><given-names>J.</given-names></name>
<name><surname>Yamamoto</surname><given-names>S.</given-names></name>
</person-group><article-title>Characterization of A Gene Encoding the Outer Membrane Receptor for Ferric Enterobactin in <italic toggle="yes">Aeromonas hydrophila</italic> ATCC 7966(T)</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2013</year><volume>77</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1271/bbb.120774</pub-id><pub-id pub-id-type="pmid">23391908</pub-id>
</element-citation></ref><ref id="B7-vaccines-13-00195"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balado</surname><given-names>M.</given-names></name>
<name><surname>Souto</surname><given-names>A.</given-names></name>
<name><surname>Vences</surname><given-names>A.</given-names></name>
<name><surname>Careaga</surname><given-names>V.P.</given-names></name>
<name><surname>Valderrama</surname><given-names>K.</given-names></name>
<name><surname>Segade</surname><given-names>Y.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>J.</given-names></name>
<name><surname>Osorio</surname><given-names>C.R.</given-names></name>
<name><surname>Jim&#x000e9;nez</surname><given-names>C.</given-names></name>
<name><surname>Lemos</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Two Catechol Siderophores, Acinetobactin and Amonabactin, Are Simultaneously Produced by <italic toggle="yes">Aeromonas salmonicida</italic> subsp. <italic toggle="yes">salmonicida</italic> Sharing Part of the Biosynthetic Pathway</article-title><source>ACS Chem. Biol.</source><year>2015</year><volume>10</volume><fpage>2850</fpage><lpage>2860</lpage><pub-id pub-id-type="pmid">26463084</pub-id>
</element-citation></ref><ref id="B8-vaccines-13-00195"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Esmaeel</surname><given-names>Q.</given-names></name>
<name><surname>Chevalier</surname><given-names>M.</given-names></name>
<name><surname>Chataign&#x000e9;</surname><given-names>G.</given-names></name>
<name><surname>Subashkumar</surname><given-names>R.</given-names></name>
<name><surname>Jacques</surname><given-names>P.</given-names></name>
<name><surname>Lecl&#x000e8;re</surname><given-names>V.</given-names></name>
</person-group><article-title>Nonribosomal Peptide Synthetase with A Unique Iterative-Alternative-Optional Mechanism Catalyzes Amonabactin Synthesis in <italic toggle="yes">Aeromonas</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2016</year><volume>100</volume><fpage>8453</fpage><lpage>8463</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7773-4</pub-id><pub-id pub-id-type="pmid">27531515</pub-id>
</element-citation></ref><ref id="B9-vaccines-13-00195"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zuo</surname><given-names>L.</given-names></name>
<name><surname>Kuo</surname><given-names>W.T.</given-names></name>
<name><surname>Turner</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Tight Junctions as Targets and Effectors of Mucosal Immune Homeostasis</article-title><source>Cell. Mol. Gastroenterol. Hepatol.</source><year>2020</year><volume>10</volume><fpage>327</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2020.04.001</pub-id><pub-id pub-id-type="pmid">32304780</pub-id>
</element-citation></ref><ref id="B10-vaccines-13-00195"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wroblewski</surname><given-names>L.E.</given-names></name>
<name><surname>Piazuelo</surname><given-names>M.B.</given-names></name>
<name><surname>Chaturvedi</surname><given-names>R.</given-names></name>
<name><surname>Schumacher</surname><given-names>M.</given-names></name>
<name><surname>Aihara</surname><given-names>E.</given-names></name>
<name><surname>Feng</surname><given-names>R.</given-names></name>
<name><surname>Noto</surname><given-names>J.M.</given-names></name>
<name><surname>Delgado</surname><given-names>A.</given-names></name>
<name><surname>Israel</surname><given-names>D.A.</given-names></name>
<name><surname>Zavros</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Helicobacter pylori</italic> Targets Cancer-Associated Apical-Junctional Constituents in Gastroids and Gastric Epithelial Cells</article-title><source>Gut</source><year>2015</year><volume>64</volume><fpage>720</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2014-307650</pub-id><pub-id pub-id-type="pmid">25123931</pub-id>
</element-citation></ref><ref id="B11-vaccines-13-00195"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harrer</surname><given-names>A.</given-names></name>
<name><surname>B&#x000fc;cker</surname><given-names>R.</given-names></name>
<name><surname>Boehm</surname><given-names>M.</given-names></name>
<name><surname>Zarzecka</surname><given-names>U.</given-names></name>
<name><surname>Tegtmeyer</surname><given-names>N.</given-names></name>
<name><surname>Sticht</surname><given-names>H.</given-names></name>
<name><surname>Schulzke</surname><given-names>J.D.</given-names></name>
<name><surname>Backert</surname><given-names>S.</given-names></name>
</person-group><article-title><italic toggle="yes">Campylobacter jejuni</italic> Enters Gut Epithelial Cells and Impairs Intestinal Barrier Function through Cleavage of Occludin by Serine Protease HtrA</article-title><source>Gut Pathog.</source><year>2019</year><volume>11</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.1186/s13099-019-0283-z</pub-id><pub-id pub-id-type="pmid">30805031</pub-id>
</element-citation></ref><ref id="B12-vaccines-13-00195"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakaguchi</surname><given-names>T.</given-names></name>
<name><surname>K&#x000f6;hler</surname><given-names>H.</given-names></name>
<name><surname>Gu</surname><given-names>X.</given-names></name>
<name><surname>McCormick</surname><given-names>B.A.</given-names></name>
<name><surname>Reinecker</surname><given-names>H.C.</given-names></name>
</person-group><article-title><italic toggle="yes">Shigella flexneri</italic> Regulates Tight Junction-Associated Proteins in Human Intestinal Epithelial Cells</article-title><source>Cell. Microbiol.</source><year>2002</year><volume>4</volume><fpage>367</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1046/j.1462-5822.2002.00197.x</pub-id><pub-id pub-id-type="pmid">12067320</pub-id>
</element-citation></ref><ref id="B13-vaccines-13-00195"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Syakuri</surname><given-names>H.</given-names></name>
<name><surname>Jung-Schroers</surname><given-names>V.</given-names></name>
<name><surname>Adamek</surname><given-names>M.</given-names></name>
<name><surname>Brogden</surname><given-names>G.</given-names></name>
<name><surname>Irnazarow</surname><given-names>I.</given-names></name>
<name><surname>Steinhagen</surname><given-names>D.</given-names></name>
</person-group><article-title>Beta-Glucan Feeding Differentiated the Regulation of Mrna Expression of Claudin Genes and Prevented an Intestinal Inflammatory Response Post <italic toggle="yes">Aeromonas Hydrophila</italic> Intubation in Common Carp, <italic toggle="yes">Cyprinus carpio</italic> L.</article-title><source>J. Fish Dis.</source><year>2014</year><volume>37</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1111/jfd.12121</pub-id><pub-id pub-id-type="pmid">23944989</pub-id>
</element-citation></ref><ref id="B14-vaccines-13-00195"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kong</surname><given-names>W.G.</given-names></name>
<name><surname>Li</surname><given-names>S.S.</given-names></name>
<name><surname>Chen</surname><given-names>X.X.</given-names></name>
<name><surname>Huang</surname><given-names>Y.Q.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>Z.X.</given-names></name>
</person-group><article-title>A Study of the Damage of the Intestinal Mucosa Barrier Structure and Function of <italic toggle="yes">Ctenopharyngodon idella</italic> with <italic toggle="yes">Aeromonas hydrophila</italic></article-title><source>Fish Physiol. Biochem.</source><year>2017</year><volume>43</volume><fpage>1223</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1007/s10695-017-0366-z</pub-id><pub-id pub-id-type="pmid">28425012</pub-id>
</element-citation></ref><ref id="B15-vaccines-13-00195"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Awan</surname><given-names>F.</given-names></name>
<name><surname>Lu</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Inhibition of <italic toggle="yes">Aeromonas hydrophila</italic>-Induced Intestinal Inflammation and Mucosal Barrier Function Damage in Crucian Carp by Oral Administration of <italic toggle="yes">Lactococcus lactis</italic></article-title><source>Fish Shellfish Immunol.</source><year>2018</year><volume>83</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2018.09.041</pub-id><pub-id pub-id-type="pmid">30236608</pub-id>
</element-citation></ref><ref id="B16-vaccines-13-00195"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Hu</surname><given-names>N.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>M.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
</person-group><article-title><italic toggle="yes">Aeromonas hydrophila</italic> Ssp1: A Secretory Serine Protease that Disrupts Tight Junction Integrity and is essential for Host Infection</article-title><source>Fish Shellfish Immunol.</source><year>2022</year><volume>127</volume><fpage>530</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2022.06.068</pub-id><pub-id pub-id-type="pmid">35798244</pub-id>
</element-citation></ref><ref id="B17-vaccines-13-00195"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>Q.</given-names></name>
<name><surname>Qiang</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>P.</given-names></name>
<name><surname>Hu</surname><given-names>N.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
</person-group><article-title>WbuB, a Glycosyltransferase Family 4 Protein, Regulates the Activation of NLRP3 Inflammasome and Contributes to the Virulence of <italic toggle="yes">Aeromonas hydrophila</italic> CCL1</article-title><source>Rep. Bre.</source><year>2023</year><volume>4</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.repbre.2023.12.006</pub-id></element-citation></ref><ref id="B18-vaccines-13-00195"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taha</surname><given-names>M.D.</given-names></name>
<name><surname>Didinen</surname><given-names>B.I.</given-names></name>
<name><surname>Emek Onuk</surname><given-names>E.</given-names></name>
<name><surname>Metin</surname><given-names>S.</given-names></name>
<name><surname>Yilmaz</surname><given-names>S.</given-names></name>
<name><surname>Mohamed</surname><given-names>A.A.</given-names></name>
<name><surname>Pak&#x00131;r</surname><given-names>S.</given-names></name>
<name><surname>G&#x000fc;l&#x0015f;en</surname><given-names>O.</given-names></name>
<name><surname>Abdel-Latif</surname><given-names>H.M.R.</given-names></name>
</person-group><article-title>Identification of Four Autochthonous Yeasts from the Intestines of Goldfish, <italic toggle="yes">Carassius auratus</italic> with Potential Probiotic Properties and their Effects on the Most Common Fish Bacterial Pathogens</article-title><source>Microb. Pathog.</source><year>2023</year><volume>184</volume><fpage>106381</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2023.106381</pub-id><pub-id pub-id-type="pmid">37806502</pub-id>
</element-citation></ref><ref id="B19-vaccines-13-00195"><label>19.</label><element-citation publication-type="book"><std>GB/T 35892-2018</std><source>Laboratory Animal-Guideline for Ethical Review of Animal Welfare</source><publisher-name>Standards Press of China</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2018</year></element-citation></ref><ref id="B20-vaccines-13-00195"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>C.M.H.</given-names></name>
<name><surname>Vilas-Boas</surname><given-names>&#x000c2;.</given-names></name>
<name><surname>Sousa</surname><given-names>C.A.</given-names></name>
<name><surname>Soares</surname><given-names>H.M.V.M.</given-names></name>
<name><surname>Soares</surname><given-names>E.V.</given-names></name>
</person-group><article-title>Comparison of Five Bacterial Strains Producing Siderophores with Ability to Chelate Iron Under Alkaline Conditions</article-title><source>AMB Express</source><year>2019</year><volume>9</volume><fpage>78</fpage><pub-id pub-id-type="doi">10.1186/s13568-019-0796-3</pub-id><pub-id pub-id-type="pmid">31139942</pub-id>
</element-citation></ref><ref id="B21-vaccines-13-00195"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Metin</surname><given-names>S.</given-names></name>
<name><surname>Yigit</surname><given-names>N.O.</given-names></name>
<name><surname>Didinen</surname><given-names>B.I.</given-names></name>
<name><surname>Koca</surname><given-names>S.B.</given-names></name>
<name><surname>Ozmen</surname><given-names>O.</given-names></name>
<name><surname>Aslankoc</surname><given-names>R.</given-names></name>
<name><surname>Kara</surname><given-names>N.</given-names></name>
</person-group><article-title>Effects of Sage (<italic toggle="yes">Salvia officinalis</italic>) Essential Oil on Growth, Health and Antioxidant Capacity of Common Carp (<italic toggle="yes">Cyprinus carpio</italic>)</article-title><source>Vet. Res. Commun.</source><year>2024</year><volume>48</volume><fpage>911</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1007/s11259-023-10267-y</pub-id><pub-id pub-id-type="pmid">38012472</pub-id>
</element-citation></ref><ref id="B22-vaccines-13-00195"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Szczygie&#x00142;</surname><given-names>J.</given-names></name>
<name><surname>Kami&#x00144;ska-Gibas</surname><given-names>T.</given-names></name>
<name><surname>Petit</surname><given-names>J.</given-names></name>
<name><surname>Jurecka</surname><given-names>P.</given-names></name>
<name><surname>Wiegertjes</surname><given-names>G.</given-names></name>
<name><surname>Irnazarow</surname><given-names>I.</given-names></name>
</person-group><article-title>Re-evaluation of Common Carp (<italic toggle="yes">Cyprinus carpio</italic> L.) Housekeeping Genes for Gene Expression Studies&#x02014;Considering Duplicated Genes</article-title><source>Fish Shellfish Immunol.</source><year>2021</year><volume>115</volume><fpage>58</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2021.05.013</pub-id><pub-id pub-id-type="pmid">34033909</pub-id>
</element-citation></ref><ref id="B23-vaccines-13-00195"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>M.</given-names></name>
<name><surname>Okamura</surname><given-names>Y.</given-names></name>
<name><surname>Kono</surname><given-names>T.</given-names></name>
<name><surname>Sakai</surname><given-names>M.</given-names></name>
<name><surname>Hikima</surname><given-names>J.I.</given-names></name>
</person-group><article-title>Interleukin-22 Induces Immune-Related Gene Expression in the Gills of Japanese medaka <italic toggle="yes">Oryzias latipes</italic></article-title><source>Dev. Comp. Immunol.</source><year>2023</year><volume>148</volume><fpage>104916</fpage><pub-id pub-id-type="doi">10.1016/j.dci.2023.104916</pub-id><pub-id pub-id-type="pmid">37591365</pub-id>
</element-citation></ref><ref id="B24-vaccines-13-00195"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Vincenzo</surname><given-names>F.</given-names></name>
<name><surname>Del Gaudio</surname><given-names>A.</given-names></name>
<name><surname>Petito</surname><given-names>V.</given-names></name>
<name><surname>Lopetuso</surname><given-names>L.R.</given-names></name>
<name><surname>Scaldaferri</surname><given-names>F.</given-names></name>
</person-group><article-title>Gut Microbiota, Intestinal Permeability, and Systemic Inflammation: A Narrative Review</article-title><source>Intern. Emerg. Med.</source><year>2024</year><volume>19</volume><fpage>275</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1007/s11739-023-03374-w</pub-id><pub-id pub-id-type="pmid">37505311</pub-id>
</element-citation></ref><ref id="B25-vaccines-13-00195"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barger</surname><given-names>P.C.</given-names></name>
<name><surname>Liles</surname><given-names>M.R.</given-names></name>
<name><surname>Newton</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Type II Secretion is Essential for Virulence of the Emerging Fish Pathogen, Hypervirulent <italic toggle="yes">Aeromonas hydrophila</italic></article-title><source>Front. Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>574113</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2020.574113</pub-id><pub-id pub-id-type="pmid">33088835</pub-id>
</element-citation></ref><ref id="B26-vaccines-13-00195"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janda</surname><given-names>J.M.</given-names></name>
<name><surname>Abbott</surname><given-names>S.L.</given-names></name>
</person-group><article-title>The Genus <italic toggle="yes">Aeromonas</italic>: Taxonomy, Pathogenicity, and Infection</article-title><source>Clin. Microbiol. Rev.</source><year>2010</year><volume>23</volume><fpage>35</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1128/CMR.00039-09</pub-id><pub-id pub-id-type="pmid">20065325</pub-id>
</element-citation></ref><ref id="B27-vaccines-13-00195"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chifman</surname><given-names>J.</given-names></name>
<name><surname>Laubenbacher</surname><given-names>R.</given-names></name>
<name><surname>Torti</surname><given-names>S.V.</given-names></name>
</person-group><article-title>A Systems Biology Approach to Iron Metabolism</article-title><source>Adv. Exp. Med. Biol.</source><year>2014</year><volume>844</volume><fpage>201</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">25480643</pub-id>
</element-citation></ref><ref id="B28-vaccines-13-00195"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maltz</surname><given-names>M.</given-names></name>
<name><surname>LeVarge</surname><given-names>B.L.</given-names></name>
<name><surname>Graf</surname><given-names>J.</given-names></name>
</person-group><article-title>Identification of Iron and Heme Utilization Genes in <italic toggle="yes">Aeromonas</italic> and their Role in the Colonization of the Leech Digestive Tract</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><elocation-id>763</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2015.00763</pub-id><pub-id pub-id-type="pmid">26284048</pub-id>
</element-citation></ref><ref id="B29-vaccines-13-00195"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barghouthi</surname><given-names>S.</given-names></name>
<name><surname>Young</surname><given-names>R.</given-names></name>
<name><surname>Olson</surname><given-names>M.O.</given-names></name>
<name><surname>Arceneaux</surname><given-names>J.E.</given-names></name>
<name><surname>Clem</surname><given-names>L.W.</given-names></name>
<name><surname>Byers</surname><given-names>B.R.</given-names></name>
</person-group><article-title>Amonabactin, a Novel Tryptophan- or Phenylalanine-Containing Phenolate Siderophore in <italic toggle="yes">Aeromonas hydrophila</italic></article-title><source>J. Bacteriol.</source><year>1989</year><volume>171</volume><fpage>1811</fpage><lpage>1816</lpage><pub-id pub-id-type="doi">10.1128/jb.171.4.1811-1816.1989</pub-id><pub-id pub-id-type="pmid">2522922</pub-id>
</element-citation></ref><ref id="B30-vaccines-13-00195"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>L.W.</given-names></name>
<name><surname>Cai</surname><given-names>S.</given-names></name>
<name><surname>Lu</surname><given-names>H.Y.</given-names></name>
<name><surname>Tang</surname><given-names>F.L.</given-names></name>
<name><surname>Zhu</surname><given-names>R.Q.</given-names></name>
<name><surname>Tian</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
</person-group><article-title>Microbiota-Derived I3A Protects the Intestine against Radiation Injury by Activating AhR/IL-10/Wnt Signaling and Enhancing the Abundance of Probiotics</article-title><source>Gut Microbes</source><year>2024</year><volume>16</volume><fpage>2347722</fpage><pub-id pub-id-type="doi">10.1080/19490976.2024.2347722</pub-id><pub-id pub-id-type="pmid">38706205</pub-id>
</element-citation></ref><ref id="B31-vaccines-13-00195"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mouries</surname><given-names>J.</given-names></name>
<name><surname>Brescia</surname><given-names>P.</given-names></name>
<name><surname>Silvestri</surname><given-names>A.</given-names></name>
<name><surname>Spadoni</surname><given-names>I.</given-names></name>
<name><surname>Sorribas</surname><given-names>M.</given-names></name>
<name><surname>Wiest</surname><given-names>R.</given-names></name>
<name><surname>Mileti</surname><given-names>E.</given-names></name>
<name><surname>Galbiati</surname><given-names>M.</given-names></name>
<name><surname>Invernizzi</surname><given-names>P.</given-names></name>
<name><surname>Adorini</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Microbiota-Driven Gut Vascular Barrier Disruption is a Prerequisite for Non-Alcoholic Steatohepatitis Development</article-title><source>J. Hepatol.</source><year>2019</year><volume>71</volume><fpage>1216</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.08.005</pub-id><pub-id pub-id-type="pmid">31419514</pub-id>
</element-citation></ref><ref id="B32-vaccines-13-00195"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jauregi-Miguel</surname><given-names>A.</given-names></name>
</person-group><article-title>The Tight Junction and the Epithelial Barrier in Coeliac Disease</article-title><source>Int. Rev. Cell Mol. Biol.</source><year>2021</year><volume>358</volume><fpage>105</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">33707052</pub-id>
</element-citation></ref><ref id="B33-vaccines-13-00195"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Backert</surname><given-names>S.</given-names></name>
<name><surname>Bernegger</surname><given-names>S.</given-names></name>
<name><surname>Sk&#x000f3;rko-Glonek</surname><given-names>J.</given-names></name>
<name><surname>Wessler</surname><given-names>S.</given-names></name>
</person-group><article-title>Extracellular HtrA Serine Proteases: An Emerging New Strategy in Bacterial Pathogenesis</article-title><source>Cell. Microbiol.</source><year>2018</year><volume>20</volume><elocation-id>e12845</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.12845</pub-id><pub-id pub-id-type="pmid">29582532</pub-id>
</element-citation></ref><ref id="B34-vaccines-13-00195"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allam-Ndoul</surname><given-names>B.</given-names></name>
<name><surname>Castonguay-Paradis</surname><given-names>S.</given-names></name>
<name><surname>Veilleux</surname><given-names>A.</given-names></name>
</person-group><article-title>Gut Microbiota and Intestinal Trans-Epithelial Permeability</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>6402</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21176402</pub-id><pub-id pub-id-type="pmid">32899147</pub-id>
</element-citation></ref><ref id="B35-vaccines-13-00195"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Jia</surname><given-names>A.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Bi</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
</person-group><article-title>The Crosstalk Between Gut Bacteria and Host Immunity in Intestinal Inflammation</article-title><source>J. Cell. Physiol.</source><year>2021</year><volume>236</volume><fpage>2239</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1002/jcp.30024</pub-id><pub-id pub-id-type="pmid">32853458</pub-id>
</element-citation></ref><ref id="B36-vaccines-13-00195"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saha</surname><given-names>P.</given-names></name>
<name><surname>Xiao</surname><given-names>X.</given-names></name>
<name><surname>Yeoh</surname><given-names>B.S.</given-names></name>
<name><surname>Chen</surname><given-names>Q.</given-names></name>
<name><surname>Katkere</surname><given-names>B.</given-names></name>
<name><surname>Kirimanjeswara</surname><given-names>G.S.</given-names></name>
<name><surname>Vijay-Kumar</surname><given-names>M.</given-names></name>
</person-group><article-title>The Bacterial Siderophore Enterobactin Confers Survival Advantage to <italic toggle="yes">Salmonella</italic> in Macrophages</article-title><source>Gut Microbes</source><year>2019</year><volume>10</volume><fpage>412</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1080/19490976.2018.1546519</pub-id><pub-id pub-id-type="pmid">30449241</pub-id>
</element-citation></ref><ref id="B37-vaccines-13-00195"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lange</surname><given-names>M.D.</given-names></name>
<name><surname>Abernathy</surname><given-names>J.</given-names></name>
<name><surname>Shoemaker</surname><given-names>C.A.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Kirby</surname><given-names>A.</given-names></name>
<name><surname>Peatman</surname><given-names>E.</given-names></name>
<name><surname>Beck</surname><given-names>B.H.</given-names></name>
</person-group><article-title>Proteome Analysis of Virulent <italic toggle="yes">Aeromonas hydrophila</italic> Reveals the Upregulation of Iron Acquisition Systems in the Presence of a Xenosiderophore</article-title><source>FEMS Microbiol. Lett.</source><year>2020</year><volume>367</volume><elocation-id>fnaa169</elocation-id><pub-id pub-id-type="doi">10.1093/femsle/fnaa169</pub-id><pub-id pub-id-type="pmid">33045069</pub-id>
</element-citation></ref><ref id="B38-vaccines-13-00195"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ren</surname><given-names>L.L.</given-names></name>
<name><surname>Zhou</surname><given-names>J.Y.</given-names></name>
<name><surname>Liang</surname><given-names>S.J.</given-names></name>
<name><surname>Wang</surname><given-names>X.Q.</given-names></name>
</person-group><article-title>Impaired Intestinal Stem Cell Activity in ETEC Infection: Enterotoxins, Cyclic Nucleotides, and Wnt Signaling</article-title><source>Arch. Toxicol.</source><year>2022</year><volume>96</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1007/s00204-021-03213-x</pub-id><pub-id pub-id-type="pmid">35226135</pub-id>
</element-citation></ref><ref id="B39-vaccines-13-00195"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ziaei</surname><given-names>A.</given-names></name>
<name><surname>Ardakani</surname><given-names>M.R.</given-names></name>
<name><surname>Hashemi</surname><given-names>M.S.</given-names></name>
<name><surname>Peymani</surname><given-names>M.</given-names></name>
<name><surname>Ghaedi</surname><given-names>K.</given-names></name>
<name><surname>Baharvand</surname><given-names>H.</given-names></name>
<name><surname>Nasr-Esfahani</surname><given-names>M.H.</given-names></name>
</person-group><article-title>Acute Course of Deferoxamine Promoted Neuronal Differentiation of Neural Progenitor Cells Through Suppression of Wnt/&#x00392;-Catenin Pathway: A Novel Efficient Protocol for Neuronal Differentiation</article-title><source>Neurosci. Lett.</source><year>2015</year><volume>590</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2015.01.083</pub-id><pub-id pub-id-type="pmid">25660235</pub-id>
</element-citation></ref><ref id="B40-vaccines-13-00195"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerner</surname><given-names>R.R.</given-names></name>
<name><surname>Hossain</surname><given-names>S.</given-names></name>
<name><surname>Sargun</surname><given-names>A.</given-names></name>
<name><surname>Siada</surname><given-names>K.</given-names></name>
<name><surname>Norton</surname><given-names>G.J.</given-names></name>
<name><surname>Zheng</surname><given-names>T.</given-names></name>
<name><surname>Neumann</surname><given-names>W.</given-names></name>
<name><surname>Nuccio</surname><given-names>S.P.</given-names></name>
<name><surname>Nolan</surname><given-names>E.M.</given-names></name>
<name><surname>Raffatellu</surname><given-names>M.</given-names></name>
</person-group><article-title>Siderophore Immunization Restricted Colonization of Adherent-Invasive <italic toggle="yes">Escherichia coli</italic> and Ameliorated Experimental Colitis</article-title><source>mBio</source><year>2022</year><volume>13</volume><elocation-id>e0218422</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.02184-22</pub-id><pub-id pub-id-type="pmid">36094114</pub-id>
</element-citation></ref><ref id="B41-vaccines-13-00195"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swain</surname><given-names>B.</given-names></name>
<name><surname>Powell</surname><given-names>C.T.</given-names></name>
<name><surname>Curtiss</surname><given-names>R.</given-names><suffix>III</suffix></name>
</person-group><article-title>Pathogenicity and Immunogenicity of <italic toggle="yes">Edwardsiella piscicida</italic> Ferric Uptake Regulator (Fur) Mutations in Zebrafish</article-title><source>Fish Shellfish Immunol.</source><year>2020</year><volume>107</volume><issue-part>Pt B</issue-part><fpage>497</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2020.10.029</pub-id><pub-id pub-id-type="pmid">33176201</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-13-00195-f001"><label>Figure 1</label><caption><p>Generation of <italic toggle="yes">Aeromonas hydrophila</italic> &#x00394;<italic toggle="yes">AmoG</italic> mutant and its complement strain &#x00394;<italic toggle="yes">AmoG</italic>-C. (<bold>A</bold>) Depiction of AmoG&#x02019;s domain. (<bold>B</bold>) PCR confirmation of the construction of &#x00394;<italic toggle="yes">AmoG</italic> mutant and &#x00394;<italic toggle="yes">AmoG</italic>-C by agarose gel electrophoresis analysis. (<bold>C</bold>) Growth levels of <italic toggle="yes">A. hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG,</italic> and &#x00394;<italic toggle="yes">AmoG</italic>-C with or without 100 &#x000b5;M 2, 2&#x02032;-dipyridyl (Dp). Values are Means &#x000b1; SEM (N = 3). Mann&#x02013;Whitney test. ** <italic toggle="yes">p</italic> &#x0003c; 0.01. (<bold>D</bold>) Representative photos of CCL1, &#x00394;<italic toggle="yes">AmoG,</italic> and &#x00394;<italic toggle="yes">AmoG</italic>-C and their siderophore production activity. CCL1, &#x00394;<italic toggle="yes">AmoG,</italic> and &#x00394;<italic toggle="yes">AmoG</italic>-C were spotted onto a filter disk in a CAS plate. One representative image from triplicate trials.</p></caption><graphic xlink:href="vaccines-13-00195-g001" position="float"/></fig><fig position="float" id="vaccines-13-00195-f002"><label>Figure 2</label><caption><p>Effect of AmoG on bacterial infection. (<bold>A</bold>) An Arnow assay was used to analyze the production of amonabactin in <italic toggle="yes">Aeromonas hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG,</italic> and &#x00394;<italic toggle="yes">AmoG</italic>-C. Caco-2 cells were challenged with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, and PBS (control) for 1 h, and their (<bold>B</bold>) adhesion index and (<bold>C</bold>) cytotoxicity were determined. Crucian carps were challenged with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) for 24 h. Iron contents in the (<bold>D</bold>) serum, (<bold>E</bold>) distal gut, and (<bold>F</bold>) liver were analyzed. (<bold>G</bold>,<bold>H</bold>) The apoptotic cells in the distal guts of infected fish were examined using a TUNEL analysis. White arrow indicates apoptotic cells. The bacterial burdens in the distal guts (<bold>I</bold>), kidneys (<bold>J</bold>), and spleens (<bold>K</bold>) were measured. Values are Means &#x000b1; SEM (N = 3). Mann&#x02013;Whitney test. ** <italic toggle="yes">p</italic> &#x0003c; 0.01. (<bold>L</bold>) Survival curves. Fish infected with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, and PBS (control) were monitored over two weeks. Log-rank test (<italic toggle="yes">p</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="vaccines-13-00195-g002" position="float"/></fig><fig position="float" id="vaccines-13-00195-f003"><label>Figure 3</label><caption><p>Transcriptomic impact of AmoG on the distal gut during <italic toggle="yes">Aeromonas hydrophila</italic> infection. Crucian carps were challenged with <italic toggle="yes">A. hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) for 24 h, and a transcriptomic analysis of their distal gut was performed. (<bold>A</bold>) Heatmap representations of differentially expressed genes upon infection with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS. Clustering reveals the genes sharing the same expression trends. Mann&#x02013;Whitney test, <italic toggle="yes">p</italic> &#x0003c; 0.01. (<bold>B</bold>) Highlighted genes exhibiting notable expression changes within identified clusters. (<bold>C</bold>&#x02013;<bold>F</bold>) KEGG pathway enrichment analysis identifying the Wnt signaling pathway as being significantly affected during <italic toggle="yes">A. hydrophila</italic> infection.</p></caption><graphic xlink:href="vaccines-13-00195-g003" position="float"/></fig><fig position="float" id="vaccines-13-00195-f004"><label>Figure 4</label><caption><p>Effect of AmoG on goblet cells and antimicrobial molecules in the distal gut. Crucian carps were challenged with <italic toggle="yes">Aeromonas hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) for 24 h. (<bold>A</bold>&#x02013;<bold>D</bold>) The expression of <italic toggle="yes">wnt3a</italic>, <italic toggle="yes">wnt10b</italic>, <italic toggle="yes">ctnnb1</italic>, and <italic toggle="yes">Lgr6</italic> in the distal guts was analyzed by qRT-PCR. (<bold>E</bold>,<bold>F</bold>) AB-PAS staining was used to show the goblet cells in the distal guts. Red arrow indicates goblet cells. Bar: 50 &#x003bc;m. (<bold>G</bold>&#x02013;<bold>J</bold>) The expression of antimicrobial genes in the distal guts was analyzed by qRT-PCR. Values are Means &#x000b1; SEM (N = 3). Mann&#x02013;Whitney test. * <italic toggle="yes">p</italic> &#x0003c; 0.05; ** <italic toggle="yes">p</italic> &#x0003c; 0.01; ns: no significance.</p></caption><graphic xlink:href="vaccines-13-00195-g004" position="float"/></fig><fig position="float" id="vaccines-13-00195-f005"><label>Figure 5</label><caption><p>Effect of AmoG on the gut mucosa barrier. Crucian carps were challenged with <italic toggle="yes">Aeromonas hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) for 24 h. The expression of (<bold>A</bold>) <italic toggle="yes">ZO-1</italic>, (<bold>B</bold>) <italic toggle="yes">Occludin</italic>, (<bold>C</bold>) <italic toggle="yes">Claudin-1</italic>, (<bold>D</bold>) <italic toggle="yes">Claudin-2</italic>, (<bold>F</bold>) <italic toggle="yes">Claudin-4,</italic> and (<bold>G</bold>) <italic toggle="yes">Claudin-8</italic> in the distal guts was determined by qRT-PCR. (<bold>E</bold>) Immunohistochemistry demonstrates Occludin&#x02019;s distribution in the distal guts. White arrow indicates the location of Occludin. Gut permeability was measured by (<bold>H</bold>) plasma D-lactic acid and (<bold>I</bold>) LPS levels. Values are Means &#x000b1; SEM (N = 3). Mann&#x02013;Whitney test. * <italic toggle="yes">p</italic> &#x0003c; 0.05, ** <italic toggle="yes">p</italic> &#x0003c; 0.01. ns: no significance.</p></caption><graphic xlink:href="vaccines-13-00195-g005" position="float"/></fig><fig position="float" id="vaccines-13-00195-f006"><label>Figure 6</label><caption><p>Effect of the Wnt signaling pathway on antibacterial immunity. Crucian carps were pre-treated with the Wnt/&#x003b2;-catenin pathway activator BIO (0.5 mg/mL) and were subsequently challenged with <italic toggle="yes">Aeromonas hydrophila</italic> CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control) for 24 h. (<bold>A</bold>) Gut permeability was analyzed using plasma LPS levels. The bacterial burdens in the (<bold>B</bold>) kidneys and (<bold>C</bold>) spleens were determined. Values are Means &#x000b1; SEM (N = 3). Mann&#x02013;Whitney test, ns: no significance. (<bold>D</bold>) Survival curves. Crucian carps were pre-treated with the Wnt/&#x003b2;-catenin pathway activator BIO as above and then were challenged with CCL1, &#x00394;<italic toggle="yes">AmoG</italic>, &#x00394;<italic toggle="yes">AmoG</italic>-C, or PBS (control). Fish were monitored over two weeks. Log-rank test (<italic toggle="yes">p</italic> &#x0003c; 0.01), ns: no significance.</p></caption><graphic xlink:href="vaccines-13-00195-g006" position="float"/></fig><table-wrap position="float" id="vaccines-13-00195-t001"><object-id pub-id-type="pii">vaccines-13-00195-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of the <italic toggle="yes">Aeromonas hydrophila AmoG</italic> mutant.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CCL1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x00394;<italic toggle="yes">AmoG</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x00394;<italic toggle="yes">AmoG</italic>-C</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Morphology <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">Ns</td><td align="center" valign="middle" rowspan="1" colspan="1">Ns</td><td align="center" valign="middle" rowspan="1" colspan="1">Ns</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Biofilm formation <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x000b1; 0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x000b1; 0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25 &#x000b1; 0.05</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Swimming motility (mm) <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13.1 &#x000b1; 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">12.8 &#x000b1; 0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">12.9 &#x000b1; 0.19</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LD<sub>50</sub> (CFU/fish) <sup>d</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.26 &#x000d7; 10<sup>4</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.58 &#x000d7; 10<sup>5</sup> **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.08 &#x000d7; 10<sup>5</sup></td></tr></tbody></table><table-wrap-foot><fn><p>Note: Values are Means &#x000b1; SD of three trials. Mann&#x02013;Whitney test or log-rank test. Ns: no significance. ** <italic toggle="yes">p</italic> &#x0003c; 0.01. <sup>a</sup>: Cell morphology was examined using electronic scanning microscopy after culturing in LB medium for 24 h at 28 &#x000b0;C. <sup>b</sup>: Bacteria were incubated in 96-well polypropylene plates for 24 h at 28 &#x000b0;C. <sup>c</sup>: The diameters of swarming colonies were measured after 24 h of incubation on LB plates containing 0.3 % agar. <sup>d</sup>: The LD&#x02085;&#x02080; values were determined in healthy crucian carp weighing an average of 14.2 g.</p></fn></table-wrap-foot></table-wrap></floats-group></article>